Printed Cornea Tissue Restores Sight in Israeli Medical Breakthrough
Summarized from The Jerusalem Post by baba
Israeli company Precise Bio has successfully restored sight to five patients using lab-grown, 3D-printed corneal implants, validating founder Aryeh Batt's decade-long vision. The breakthrough procedure, the first of its kind globally, addresses a critical shortage of donor corneas. While still in clinical trials, the technology holds promise for future tissue and organ regeneration, with potential applications for other organs within 10-15 years.
The story in 6 lines · by baba
- Precise Bio's printed corneal implants have restored sight to five patients at Rambam Health Care Campus.
- This marks the world's first transplantation of a functional, live-cell-based corneal implant produced via bioprinting.
- The technology addresses a severe global shortage of donor corneas, potentially yielding hundreds of implants from a single donor.
- The company's "4D printing" process allows for the creation of functional tissue from lab-grown cells.
- Precise Bio aims to develop printed tissues for other organs, including heart, liver, and kidney, within 10-15 years.
- German medical company Carl Zeiss Meditec invested in Precise Bio in 2022, supporting commercialization efforts.
The Jerusalem Post publishes in English. The key points are summarized above. Read The Jerusalem Post’s full report from the link at the top of the page.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 2
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
